List of insiders holdings for Tourmaline Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Ildstad Suzanne Director |
2023-06-14 18:58:15 | 3,791,892 1,308,410 |
5,100,302 | Form 4 |
2 | Requadt Scott Former Chief Executive Officer |
2023-07-06 17:19:16 | 578,403 449,766 |
1,028,169 | Form 4 |
3 | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
2023-10-30 17:16:49 | 322,077 0 |
322,077 | Form 13D |
4 | Zdanowski Michael Chief Technology Officer |
2023-02-03 17:02:36 | 300,000 0 |
300,000 | Form 4 |
5 | CHYUNG YUNG H. Chief Medical Officer |
2023-10-23 20:20:18 | 274,262 0 |
274,262 | Form 4 |
6 | Krieger Nancy Chief Medical Officer |
2023-02-03 16:59:50 | 240,000 0 |
240,000 | Form 4 |
7 | Kulkarni Sandeep Chidambar CEO |
2025-02-04 16:19:06 | 226,000 0 |
226,000 | Form 4 |
8 | Clarus Defined Exit I L.P. Clarus DE II L.P. Clarus IV-A L.P. Clarus IV-B L.P. Clarus IV-C L.P. Clarus IV-D L.P. Clarus Ventures DE GP L.P. Clarus IV GP L.P. Blackstone Clarus DE L.L.C. Blackstone Clarus GP L.L.C. 10% Owner |
2021-05-13 21:59:55 | 0 160,044 |
160,044 | Form 4 |
9 | Fenton Mary Kay Chief Financial Officer |
2023-07-06 17:20:59 | 68,054 0 |
68,054 | Form 4 |
10 | Robinson Ryan F. Chief Financial Officer |
2025-01-29 16:23:34 | 58,000 0 |
58,000 | Form 4 |
11 | MIDDLEKAUFF W BRADFORD CBO, GC and Secretary |
2025-01-29 16:23:21 | 58,000 0 |
58,000 | Form 4 |
12 | Jones Susan Dana Chief Technology Officer |
2025-01-29 16:23:10 | 58,000 0 |
58,000 | Form 4 |
13 | Johnson Kevin Bruce Chief Regulatory Officer |
2025-01-29 16:22:59 | 58,000 0 |
58,000 | Form 4 |
14 | Nader Francois Director |
2023-06-14 19:00:36 | 41,000 0 |
41,000 | Form 4 |
15 | MACKAY GEOFFREY Director |
2023-06-14 18:59:05 | 20,500 0 |
20,500 | Form 4 |
16 | Shah Gaurav Director |
2023-06-14 19:01:25 | 20,500 0 |
20,500 | Form 4 |
17 | Smith Karen L. Director |
2023-06-14 19:02:37 | 20,500 0 |
20,500 | Form 4 |
18 | Agarwala Sandip Director |
2023-06-14 18:56:33 | 20,500 0 |
20,500 | Form 4 |
19 | SIEGALL CLAY B Director |
2024-06-07 16:03:21 | 15,000 0 |
15,000 | Form 4 |
20 | Thiara Parvinder Director |
2024-06-07 16:02:30 | 10,000 0 |
10,000 | Form 4 |
21 | MCDADE MARK Director |
2024-06-07 16:03:11 | 10,000 0 |
10,000 | Form 4 |
22 | KANTOFF AARON Director |
2024-06-07 16:02:56 | 10,000 0 |
10,000 | Form 4 |
23 | Srivastava Sapna Director |
2024-06-07 16:02:42 | 10,000 0 |
10,000 | Form 4 |
24 | Castelein Caley Director |
2024-06-07 16:02:17 | 10,000 0 |
10,000 | Form 4 |
25 | Chester Cariad Director |
2023-10-23 18:27:53 | 0 0 |
0 | Form 3 |
26 | Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. Blackstone Clarus III L.L.C. Blackstone Clarus GP L.P. Blackstone Holdings I L.P. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner |
2024-02-09 17:24:53 | 0 0 |
0 | Form 13G |
27 | GALAKATOS NICHOLAS Director |
2021-05-06 21:25:52 | 0 0 |
0 | Form 3 |